Ehsan Jahandarpour
Outbound SalesHealthTechSeries Cbeginner

Outbound Sales for HealthTech at Series C

A step-by-step playbook for implementing outbound sales at a Series C-stage HealthTech company. This guide covers everything from initial setup and team requirements to execution, measurement, and optimization — tailored specifically for HealthTech companies with large budget for market leadership investment and full growth org with multiple teams and leadership. Includes specific KPIs, recommended tools, common pitfalls to avoid, and expert insights from Ehsan Jahandarpour.

Timeline: 2-4 weeks

Prerequisites

  • ✓ Established product with proven product-market fit
  • ✓ Analytics infrastructure capturing key user events
  • ✓ HIPAA, FDA, and healthcare-specific regulations require specialized compliance infrastructure — ensure compliance before scaling
  • ✓ CRM and email sequencing tools configured
  • ✓ At least 5 closed deals to validate ICP assumptions

Step-by-Step Guide

1

Define your ideal customer profile

Build a detailed ICP based on company size, industry, tech stack, funding stage, and pain points. The more specific, the higher your response rates. For HealthTech companies at the Series C stage, this step is particularly important given achieving market leadership and international expansion.

Pro tip: Analyze your last 20 closed-won deals — what do those companies have in common? In the HealthTech context, also consider: HIPAA compliance complexity.

2

Build targeted prospect lists

Use data tools to build lists of companies and decision-makers that match your ICP. Enrich with intent signals and technographic data. For HealthTech companies at the Series C stage, this step is particularly important given achieving market leadership and international expansion.

Pro tip: Prioritize companies showing buying signals: hiring for relevant roles, using competitor tools, or raising funding. In the HealthTech context, also consider: slow adoption by medical professionals.

3

Write personalized outreach sequences

Create multi-touch sequences across email, LinkedIn, and phone. Each message should reference something specific about the prospect company. For HealthTech companies at the Series C stage, this step is particularly important given achieving market leadership and international expansion.

Pro tip: First email should be under 100 words. Lead with their problem, not your product. In the HealthTech context, also consider: long procurement cycles.

4

Set up sales tech stack

Implement a CRM, email sequencer, dialer, and LinkedIn automation tool. Connect everything for unified tracking and reporting. For HealthTech companies at the Series C stage, this step is particularly important given achieving market leadership and international expansion.

Pro tip: Start with HubSpot or Salesforce + Apollo or Outreach. Do not over-tool early. In the HealthTech context, also consider: clinical validation requirements.

Expected Outcomes

  • ✓ 15-25 qualified meetings booked per SDR per month targeting HealthTech
  • ✓ Email reply rate above 8% for personalized outbound sequences
  • ✓ Outbound-sourced pipeline contributing 30-50% of total pipeline
  • ✓ Average deal size 2x higher for outbound HealthTech deals vs inbound

KPIs to Track

  • ● Sales cycle length
  • ● Win rate from outbound
  • ● Meetings booked per SDR
  • ● Email reply rate
  • ● Pipeline generated

Common Mistakes to Avoid

⚠Measuring activity instead of outcomes
⚠Not aligning outbound messaging with marketing
⚠Sending generic mass emails
⚠Not following up enough (most deals close after 5+ touches)

Ehsan's Growth Commentary

HealthTech outbound sales is the slowest-converting channel in B2B because hospital and health system procurement is designed to be slow (protecting patient safety through careful evaluation). A HealthTech company's outbound sequence might take 12-18 months from first touchpoint to signed contract. The healthtech outbound approach: target clinical champions (physicians, department heads) rather than procurement. Clinical champions who see value in your product will drive the internal procurement process — a single enthusiastic physician can accelerate procurement by 6-12 months. The outbound message should speak clinical language, not sales language. "Our AI reduced false positive rates by 23% in a peer-reviewed study at [hospital]" resonates with clinicians. "Our platform improves workflow efficiency" does not. Lead with clinical evidence, cite published studies, and offer a clinical pilot (not a "demo") — terminology matters in healthcare because it signals whether you understand the clinical environment.

The first email should be about them, not you. Lead with a specific observation about their company or role. In HealthTech, multi-threaded outreach (contacting 3+ people at the same account) increases response rates by 50%. Follow up at least 5 times. 80% of deals require 5+ touches, but 90% of salespeople give up after 2.

EJ

Ehsan Jahandarpour

AI Growth Strategist & Fractional CMO

Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council

Frequently Asked Questions

How long does it take to see results from outbound sales in HealthTech?
For HealthTech companies at the Series C stage, expect to see early signals within 4-8 weeks and meaningful results within 3-6 months. The timeline depends on your current baseline, team capacity, and large budget for market leadership investment. Focus on leading indicators early and shift to lagging indicators (revenue, retention) over time.
What budget should a Series C HealthTech company allocate to outbound sales?
At the Series C stage with large budget for market leadership investment, allocate 10-20% of your growth budget to outbound sales. For HealthTech specifically, this means investing in Epic and Redox and dedicating at least one team member 50%+ of their time. Start small, prove ROI, then scale investment proportionally.
What are the biggest risks of outbound sales for HealthTech companies?
The primary risks are: (1) spreading too thin across tactics instead of going deep on one, (2) not adapting the approach to HealthTech-specific dynamics like HIPAA compliance complexity, (3) measuring vanity metrics instead of business outcomes, and (4) giving up before the tactic has time to compound. Mitigate these by setting clear success criteria and committing to a 90-day minimum test period.
Can outbound sales work alongside other growth strategies?
Absolutely — and it should. outbound sales is most powerful when combined with complementary tactics. For HealthTech at Series C, pair it with content marketing for top-of-funnel, and a strong activation flow for conversion. The key is to avoid diluting focus: master one tactic before adding another. Think of it as stacking growth loops, not running parallel experiments.
How do I measure the ROI of outbound sales in HealthTech?
Track both leading indicators (engagement, traffic, activation) and lagging indicators (pipeline, revenue, retention). For HealthTech companies, the most important metrics are CAC from this channel, conversion rate at each funnel stage, and LTV of customers acquired through outbound sales. Set up proper attribution using UTM parameters, cohort analysis, and ideally a multi-touch attribution model. Report ROI monthly to stakeholders.